Navigation Links
Newly Updated for 2011: Medical Science Liaison Study Shows Growth in KOL Outreach, Impact
Date:3/21/2011

CHAPEL HILL, N.C., March 21, 2011 /PRNewswire/ -- Although top bio-pharmaceutical companies agree that Key Opinion Leader support is critical in the successful launch of a new product, increasing competition has made it difficult to maintain high levels of KOL engagement. Consequently, the role of Medical Science Liaisons (MSLs) in forging relationships with these thought leaders has grown dramatically in recent years.

In fact, today, MSL involvement in identifying and forging relationships with KOLs has increased by more than 20% since 2009, according to a newly-published Best Practices, LLC study entitled Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders (Updated for 2011).

As one interviewed Senior Vice President commented: "Time spent by Medical Science Liaisons in interaction [with KOLs] is now used as a metric to measure MSL effectiveness."

With interviews and key insights drawn from 27 leaders at 24 leading bio-pharmaceutical companies, this Best Practices, LLC benchmarking study identifies a wealth of strategies and proven tactics that helps Medical Affairs and other executives to effectively determine the optimal number of liaisons, mix of responsibilities, number of interactions and span of control that are critical to build strong and productive relationships over the life of a brand.

The full 78-page report contains more than 600 benchmark metrics and scores of executive narratives that companies can use to benchmark key management factors reflecting size, service levels and roles of Medical Science Liaisons in serving KOLs and hard-to-see physicians.

Additionally, this critical report provides a series of fascinating longitudinal data comparisons from 2009 - the date of Best Practices, LLC's original study on the topic – and a host of current data from 2011 enabling executives to capitalize on new trends which animate MSL strategy throughout the industry.

Key topics of this primary research include:

  • Benchmark pre and post-launch service activities
  • Identify drivers of group size & focus
  • Gain insight into structuring & aligning medical with sales organizations
  • Identify optimal call frequencies and service levels with thought leaders
  • Identify relationship management standards of excellence
  • Identify value associated with MSL and the activities they perform
  • Budget allocation to MSL function  

To learn more about the study, download a complimentary summary at http://www.best-in-class.com/rr1045.htm

For more information, contact Cameron Tew, Executive Director of Research and Publishing at Best Practices, LLC at (919) 767-9246 or ctew@best-in-class.com.

BEST PRACTICES, LLC conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
2. Newly Integrated Software Suite From ZS Associates Offers Comprehensive Set of Sales Performance Management Software Solutions
3. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
4. Prometheus Strengthens Intellectual Property Portfolio with Newly Issued Patents for Thiopurine Metabolite Testing
5. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
6. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
7. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
8. Hospira Supports Newly Introduced Biogenerics Legislation
9. febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
10. Titanium and Aluminum Distributor, Trans World Alloys Relocates to Its Newly Built, State-of-the-Art Headquarters in Gardena, California
11. RBC Life Sciences Fills Newly Created Vice President of Sales and Marketing Position With Industry Veteran
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):